Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1

By Devico A.L.   Fouts T.R.   Shata M.T.   Kamin-Lewis R.   Lewis G.K.   Hone D.M.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1968-1974

Elsevier

Access to resources Recommend Favorite

Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV

By Fernandez I.M.   Golding H.   Benaissa-Trouw B.J.   de Vos N.M.   Harmsen M.   Nottet H.S.L.M.   Golding B.   Puijk W.C.   Meloen R.H.   Snippe H.   Kraaijeveld C.A.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1936-1940

Elsevier

Access to resources Recommend Favorite

HIV-1 candidate vaccines can induce antibodies which share specificity with human monoclonal antibodies capable of neutralizing primary isolates

By Davis D.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 353-354

Elsevier

Access to resources Recommend Favorite

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa

By Machado A.A.   Baknabua M.   Salaun D.   de Mareuil J.   Krciinak V.   MacGregor R.R.   Chermann J.-C.   Hirsch I.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite

Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL

By Dominici S.   Laguardia M.E.   Serafini G.   Chiarantini L.   Fortini C.   Tripiciano A.   Brocca-Cofano E.   Scoglio A.   Caputo A.   Fiorelli V.   Gavioli R.   Cafaro A.   Ensoli B.   Magnani M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite